Suppr超能文献

用于预测食管静脉曲张的非侵入性纤维化标志物:内镜筛查的潜在替代方法

Non-invasive Fibrosis Markers for Predicting Esophageal Varices: A Potential Alternative to Endoscopic Screening.

作者信息

Ali Kunza, Slah-Ud-Din Saad, Afzal Mishal, Tariq Mah R, Waheed Tallha, Yousuf Haroon

机构信息

Medicine and Surgery, Shalamar Medical & Dental College, Lahore, PAK.

Internal Medicine, Shalamar Medical & Dental College, Lahore, PAK.

出版信息

Cureus. 2024 Mar 19;16(3):e56433. doi: 10.7759/cureus.56433. eCollection 2024 Mar.

Abstract

BACKGROUND

Chronic liver infections and diseases lead to chronic liver injury, which results in fibrosis. Due to this continuous scarring and regeneration, cirrhosis occurs, which is also responsible for several adverse sequelae, including but not limited to esophageal varices. Cirrhosis has resulted in patients' increased morbidity and mortality, especially in low socioeconomic settings such as Pakistan. Endoscopy is the gold standard for measuring the presence or absence of esophageal varices, along with their grade. Currently, some non-invasive markers (aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), fibrosis 4 (FIB-4), AAR to platelet ratio index (AARPRI), aspartate aminotransferase-to-platelet ratio index (APRI), S-index, King's score) are being established that make use of laboratory tests, such as a complete blood profile, liver function profile, and coagulation profile, to estimate the extent of hepatic fibrosis.

OBJECTIVES

The objective of this study is to establish a correlation between non-invasive markers of fibrosis and the presence of esophageal varices and to assess their potential as a substitute for gastrointestinal endoscopy screening. Additionally, the study aims to compare these six scores, thereby generating data on their individual and relative accuracy.

METHODOLOGY

This was a cross-sectional study conducted at the Shalamar Institute of Health Sciences, Lahore, Pakistan. Outpatient (OPD) data were obtained from the Shalamar online portal system from June 2022 to December 2022. Laboratory tests, abdominal ultrasounds, and endoscopy results were accessed and recorded in the questionnaire. The patient's medical records and contact numbers were also noted in case further questions arose. Data were then compiled into a Microsoft Excel spreadsheet (Microsoft Corp., Redmond, WA) and analyzed after computing the non-invasive procedure formulas. It was analyzed using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY). P-values were calculated, and conclusions were drawn.

RESULTS

Of the sample size of 100 patients with liver damage and injury, 60% were male and 40% were female. Among males, 15% had a milder (grade 1) degree of esophageal varices, and 45% had a moderate to advanced degree (grades 2-3) of esophageal varices. Among females, 19% had mild (grade 1) varices, while 21% had severe (grade 3) varices. The most common cause of varices in patients who had developed fibrosis and/or cirrhosis was hepatitis C, with a wide margin of other causes. The p-values obtained showed that from the selected list of non-invasive markers of fibrosis, only FIB-4 and AARPRI were statistically significant with p-values of 0.036 and 0.022, respectively.

PRACTICAL IMPLICATIONS

Though endoscopy is currently the gold-standard procedure for detecting the presence or absence and grade of esophageal varices, it is invasive, which makes the patients extremely uncomfortable and apprehensive. It can also lead to post-procedure infection, internal hemorrhages, and trauma due to instrument use. Due to its invasive nature, some patients also tend to refuse this procedure. Non-invasive fibrosis markers can help make a diagnosis without undergoing an endoscopy, which in turn will improve patient compliance and satisfaction.

CONCLUSION

It was observed that FIB-4 and AARPRI can be used together as reliable markers to assess the presence or absence of esophageal varices.

摘要

背景

慢性肝脏感染和疾病会导致慢性肝损伤,进而引发肝纤维化。由于这种持续的瘢痕形成和再生,会出现肝硬化,而肝硬化也是包括但不限于食管静脉曲张等多种不良后果的原因。肝硬化导致患者的发病率和死亡率增加,在巴基斯坦等社会经济水平较低的地区尤其如此。内镜检查是检测食管静脉曲张是否存在及其分级的金标准。目前,一些利用全血细胞计数、肝功能检查和凝血功能检查等实验室检测来评估肝纤维化程度的非侵入性标志物(天冬氨酸转氨酶与丙氨酸转氨酶比值(AAR)、纤维化4(FIB-4)、AAR与血小板比值指数(AARPRI)、天冬氨酸转氨酶与血小板比值指数(APRI)、S指数、金斯评分)正在建立。

目的

本研究的目的是建立纤维化的非侵入性标志物与食管静脉曲张存在之间的相关性,并评估它们作为胃肠内镜筛查替代方法的潜力。此外,该研究旨在比较这六个评分,从而得出它们各自的准确性和相对准确性的数据。

方法

这是一项在巴基斯坦拉合尔沙勒马健康科学研究所进行的横断面研究。2022年6月至2022年12月期间从沙勒马在线门户系统获取门诊(OPD)数据。在问卷中获取并记录实验室检查、腹部超声和内镜检查结果。还记录了患者的病历和联系电话,以防出现进一步的问题。然后将数据整理到Microsoft Excel电子表格(微软公司,华盛顿州雷德蒙德)中,并在计算非侵入性检查公式后进行分析。使用IBM SPSS Statistics for Windows 20.0版(IBM公司,纽约州阿蒙克)进行分析。计算P值并得出结论。

结果

在100例肝损伤患者样本中(原文是liver damage and injury,感觉这里表述不太准确,可能是liver diseases之类的,不过按原文翻译),60%为男性,40%为女性。在男性中,15%有轻度(1级)食管静脉曲张,45%有中度至重度(2 - 3级)食管静脉曲张。在女性中,19%有轻度(1级)静脉曲张,而21%有重度(3级)静脉曲张。已发生纤维化和/或肝硬化的患者中,静脉曲张最常见的原因是丙型肝炎,其他原因占比差距较大。所获得的P值表明,从选定的纤维化非侵入性标志物列表中,只有FIB-4和AARPRI具有统计学意义,P值分别为0.036和0.022。

实际意义

虽然目前内镜检查是检测食管静脉曲张是否存在及其分级的金标准程序,但它具有侵入性,这会让患者极度不适和担忧。它还可能导致术后感染、内出血以及因器械使用造成的创伤。由于其侵入性,一些患者也倾向于拒绝该检查。非侵入性纤维化标志物有助于在不进行内镜检查的情况下做出诊断,这反过来将提高患者的依从性和满意度。

结论

观察到FIB-4和AARPRI可一起用作评估食管静脉曲张是否存在的可靠标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6854/11024663/ff15f2271747/cureus-0016-00000056433-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验